DrugsControl Media Services
DrugsControl.org

News Detail

Biocon Biologics to reduce the cost of human insulin and cancer drugs (02-12-2019)

Bengaluru, 2 Dec 2019: Biocon Biologics is focusing on innovative business models to reduce the cost of human insulin and cancer drugs, as it looks to build a pipeline of 28 biosimilars across global markets, the company’s chief executive said.

 

The Bi......
View Details

Source : Economic Times

Related News